Generate Biomedicines
$14.40
36
-$0.06-0.41% 14:08 Today
Statistics
Day High
14.49
Day Low
14.45
52W High
22.67
52W Low
11
Volume
32,170
Avg. Volume
-
Mkt Cap
1.86B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Dec 2Expected
Q1 2026
Q2 2026
Next
-1.07
-0.88
-0.7
-0.51
Expected EPS
-0.556667
Actual EPS
N/A
Financials
-782.38%Profit Margin
Unprofitable31.89MRevenue
-249.52MNet Income
Analyst Ratings
$26.00Average Price Target
The highest estimate is 30.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow GENB. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.
Show More
CEO
Michael T. Nally
Employees
312
Country
United States
ISIN
US3709201004
Listings
0 Comments
Share your thoughts
FAQs
What is Generate Biomedicines stock price today?▼
The current price of GENB is $14.40 USD — it has decreased by -0.41% in the past 24 hours. Watch Generate Biomedicines stock price performance more closely on the chart.
What is Generate Biomedicines stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Generate Biomedicines stocks are traded under the ticker GENB.
What is Generate Biomedicines market cap?▼
Today Generate Biomedicines has the market capitalization of 1.86B
When is the next Generate Biomedicines earnings date?▼
Generate Biomedicines is going to release the next earnings report on December 2, 2026.
What were Generate Biomedicines earnings last quarter?▼
GENB earnings for the last quarter are -0.52 USD per share, whereas the estimation was -0.51 USD resulting in a -2.3% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Generate Biomedicines revenue for the last year?▼
Generate Biomedicines revenue for the last year amounts to 31.89M USD.
What is Generate Biomedicines net income for the last year?▼
GENB net income for the last year is -249.52M USD.
How many employees does Generate Biomedicines have?▼
As of November 2, 2026, the company has 312 employees.
In which sector is Generate Biomedicines located?▼
Generate Biomedicines operates in the Health & Wellness sector.
When did Generate Biomedicines complete a stock split?▼
Generate Biomedicines has not had any recent stock splits.
Where is Generate Biomedicines headquartered?▼
Generate Biomedicines is headquartered in SOMERVILLE, United States.